Cargando…
A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK
BACKGROUND: A live-attenuated vaccine aimed at preventing herpes zoster (HZ) and its main complication, post-herpetic neuralgia (PHN) is available in Europe for immunocompetent adults aged 50 years and more. The study objective is to assess the cost effectiveness of a vaccination program for this po...
Autores principales: | Moore, Lee, Remy, Vanessa, Martin, Monique, Beillat, Maud, McGuire, Alistair |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881001/ https://www.ncbi.nlm.nih.gov/pubmed/20433704 http://dx.doi.org/10.1186/1478-7547-8-7 |
Ejemplares similares
-
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study
por: Gialloreti, Leonardo Emberti, et al.
Publicado: (2010) -
Burden of herpes zoster and post-herpetic neuralgia in Sweden
por: Nilsson, Jonas, et al.
Publicado: (2015) -
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
por: Johnson, Robert W, et al.
Publicado: (2010) -
A Cost-Effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia
por: Carpenter, Christopher, et al.
Publicado: (2017) -
A Cost-effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-herpetic Neuralgia
por: Carpenter, Christopher F, et al.
Publicado: (2019)